The shared pathway between cortisol and sex hormones
Steroid hormone production in the body begins with a single precursor molecule, pregnenolone, synthesised from cholesterol. From this starting point, the pathway branches into multiple downstream hormones, including cortisol, progesterone, testosterone, and estrogen, through a sequence of enzymatic conversions.
This shared origin means that cortisol and the sex hormones are not produced by entirely separate systems that happen to interact. They are produced from a common upstream resource, and the rate at which that resource is directed toward cortisol production versus sex hormone production depends on the relative demand the body is experiencing in each direction at any given time.
Under typical, non-chronic conditions, this branching system allows the body to flexibly meet whatever hormonal demand is present without one pathway being permanently disadvantaged. Under chronic stress, the system changes. Sustained, ongoing cortisol demand does not represent a temporary diversion that resolves once the immediate need passes. It represents a continuous pull on the shared precursor pathway, and over time, this continuous pull measurably reduces the resources available for sex hormone synthesis.
This mechanism, sometimes referred to informally as the pregnenolone steal or cortisol shunt, is a useful simplification of a more complex enzymatic reality, but the practical clinical observation it describes, that chronic cortisol elevation correlates with reduced sex hormone output, is well-documented and consistently observed in both research and clinical practice.
How this presents in women
In women, the cortisol-hormone connection most commonly presents as a shift in the ratio between progesterone and estrogen, because progesterone is more directly affected by the shared pregnenolone pathway than estrogen is in most cases.
As cortisol demand increases under chronic stress, progesterone production tends to decline relative to estrogen, even when estrogen levels themselves remain within a normal range. This relative shift, progesterone too low relative to estrogen, rather than estrogen being abnormally high in absolute terms, is the clinical pattern known as estrogen dominance, and it is one of the most common hormonal patterns identified in women experiencing chronic occupational stress.
The downstream effects of this shift are wide-ranging because progesterone has a calming, balancing effect on mood and the nervous system, supports healthy sleep, and counterbalances some of estrogen's more stimulating effects on tissue growth and water retention. When progesterone declines relative to estrogen, the symptoms that emerge, more severe PMS, increased irritability and mood volatility in the luteal phase, heavier or more irregular periods, increased breast tenderness, and water retention, reflect estrogen's relatively unopposed effects rather than a problem with estrogen production itself.
This pattern explains why many women experience a worsening of cycle-related symptoms specifically during periods of heightened occupational stress, and why this worsening often does not respond to interventions focused solely on the menstrual cycle without addressing the underlying cortisol demand driving the progesterone decline.
How this presents in men
In men, the primary pathway affected by chronic cortisol elevation is not the pregnenolone steal in the same direct sense as in women, but the suppression of luteinising hormone (LH) signalling from the pituitary gland, which is the hormone that drives testosterone production in the testes.
Chronic stress elevates levels of corticotropin-releasing hormone (CRH), which directly suppresses the pituitary's release of LH. Reduced LH signalling means reduced stimulation for testosterone synthesis, producing a pattern of declining testosterone that tracks closely with the duration and severity of the chronic stress exposure rather than occurring as an isolated hormonal event.
This presents practically as reduced libido, slower recovery from physical exertion, reduced muscle maintenance despite consistent training, lower drive and motivation, and a flatter overall affect that is frequently attributed to general tiredness or the grind of the job rather than recognised as a measurable hormonal consequence of sustained stress.
Men in physically demanding, high-responsibility roles, which describes much of yacht crew work, particularly in positions like first mate or captain that combine physical demand with sustained decision-making responsibility, are a population in whom this pattern is both common and frequently undiagnosed, because conventional testosterone testing is rarely initiated unless symptoms are severe, and the connection to occupational stress specifically is rarely made without functional testing.
The bidirectional relationship between hormones and stress
The connection between chronic stress and hormonal imbalance does not run in only one direction. Once hormonal imbalance is established, it tends to worsen the body's capacity to manage stress, creating a cycle that does not resolve on its own.
Lower progesterone in women removes a hormone that has a direct calming effect on the nervous system through its interaction with GABA receptors, meaning that as progesterone declines due to chronic stress, the nervous system loses one of its own buffering mechanisms against further stress, making the individual more reactive to subsequent stressors, not less.
Lower testosterone in men is associated with reduced resilience, lower mood, and reduced capacity to recover from physical and psychological demands, again removing a buffer that would otherwise help the system manage ongoing stress more effectively.
This bidirectional relationship is part of why chronic stress and hormonal symptoms so often present together rather than as isolated issues, and why addressing only one side of the cycle, managing stress without supporting the hormonal depletion, or supporting hormones without addressing the ongoing stress demand, tends to produce incomplete or temporary improvement. The most effective approach treats both sides of the cycle simultaneously, informed by what the actual lab data shows about where the disruption currently sits.
Belinda's Perspective
What my own three-year hormone data showed about this connection
The clearest evidence I have of this connection in my own body comes from comparing my hormone testing across multiple years rather than any single panel. My Pg/E2 ratio, the progesterone-to-estradiol ratio that reflects exactly the cortisol-hormone pattern described above, was low across all three years of testing I have on file: 31, then 20, then 21. Not a single bad reading. A consistent, multi-year pattern that did not resolve on its own and, if anything, worsened before it began to shift.
What I find most instructive about this data, looking back, is that it tracks alongside my cortisol pattern across the same years, not as a coincidence, but as the connected system described above. My noon cortisol was elevated, and eventually my night cortisol became elevated too. The progesterone-to-estrogen ratio stayed low throughout. Two patterns, one underlying driver.
At the time, I did not think of my hormonal symptoms and my stress load as the same problem. I thought of them as two separate things to eventually deal with separately. What the multi-year data taught me is that they were never separate. The years of sustained demand, the freelance and racing years before the world sailing tour for charity, the tour itself, months of offshore sailing combined with a heavy schedule of onshore events and appearances with very little genuine downtime, all of it was continuously pulling on the same pathway that should have been producing progesterone.
What I want crew, particularly women, to understand from this is that if your hormonal symptoms are not responding to interventions aimed directly at your cycle or your hormones, the question worth asking is not what else can I try hormonally, but what is my cortisol pattern doing, and has anyone actually looked. In my experience, and in the data from the crew I now work with, that question is the one that's usually been missing.
Sources
- Whirledge S, Cidlowski JA. Glucocorticoids, stress, and fertility. Minerva Endocrinologica, 2010.
- Toufexis D, et al. Stress and the reproductive axis. Journal of Neuroendocrinology, 2014.
- Whirledge S, Cidlowski JA. A role for glucocorticoids in stress-impaired reproduction: beyond the hypothalamus and pituitary. Endocrinology, 2013.
- Hardy MP, et al. Stress hormone and male reproductive function. Cell and Tissue Research, 2005.
- Schmidt PJ, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. American Journal of Obstetrics and Gynecology, 2000.
